Agreed, it's hard to gauge. Looking at the criteria for Provisional Approval, we don't need to be lifesaving anyway, we just need to show it's a major therapeutic advance (and compares favorably to existing therapies). Blind Freddie can see we satisfy that criterion.
If I were a decision maker at the TGA I would be saying to PAR that they do not have an actionable plan - until the FDA allows us to proceed with P3 and a deal is done to fund it, we cannot demonstrate that we are able to action any plan to provide further comprehensive clinical data.
I suspect they won't let us pursue the PA without those two milestones met. And perhaps they would like to see what data we will be collecting (based on FDA feedback) before they can say our plan is a sound one.
- Forums
- ASX - By Stock
- research reports and media
Agreed, it's hard to gauge. Looking at the criteria for...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
-0.015(5.88%) |
Mkt cap ! $84.05M |
Open | High | Low | Value | Volume |
25.5¢ | 26.5¢ | 24.0¢ | $167.2K | 671.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 108741 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.5¢ | 9700 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 108741 | 0.240 |
4 | 64258 | 0.235 |
8 | 113649 | 0.230 |
5 | 71572 | 0.225 |
5 | 55537 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.255 | 1600 | 1 |
0.260 | 62000 | 2 |
0.265 | 66950 | 4 |
0.270 | 35288 | 4 |
0.275 | 23636 | 3 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online